Jie-Jen Lee

1.3k total citations
34 papers, 1.1k citations indexed

About

Jie-Jen Lee is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Immunology. According to data from OpenAlex, Jie-Jen Lee has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Immunology. Recurrent topics in Jie-Jen Lee's work include Thyroid Cancer Diagnosis and Treatment (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Antioxidant Activity and Oxidative Stress (3 papers). Jie-Jen Lee is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Antioxidant Activity and Oxidative Stress (3 papers). Jie-Jen Lee collaborates with scholars based in Taiwan, India and Egypt. Jie-Jen Lee's co-authors include Joen‐Rong Sheu, Thanasekaran Jayakumar, Yi‐Chiung Hsu, Shih‐Ping Cheng, Cheng-Ying Hsieh, Chien‐Liang Liu, George Hsiao, Ming-Jen Chen, Duen‐Suey Chou and Shih‐Yuan Huang and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Journal of Agricultural and Food Chemistry.

In The Last Decade

Jie-Jen Lee

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie-Jen Lee Taiwan 19 364 260 180 176 172 34 1.1k
Yueh-Min Lin Taiwan 25 649 1.8× 184 0.7× 290 1.6× 109 0.6× 125 0.7× 62 1.4k
Zheng Yang China 28 814 2.2× 117 0.5× 144 0.8× 113 0.6× 134 0.8× 51 1.7k
Xiangming Qi China 21 416 1.1× 160 0.6× 56 0.3× 114 0.6× 208 1.2× 50 1.1k
Baolin Liu China 22 556 1.5× 139 0.5× 118 0.7× 119 0.7× 81 0.5× 53 1.3k
Bogusław Czerny Poland 16 328 0.9× 141 0.5× 199 1.1× 77 0.4× 140 0.8× 110 1.1k
Chunlai Zeng China 20 413 1.1× 158 0.6× 83 0.5× 79 0.4× 116 0.7× 48 1.1k
Xi Dong China 26 791 2.2× 167 0.6× 121 0.7× 116 0.7× 242 1.4× 60 1.7k
Hai‐Han Liao China 23 666 1.8× 92 0.4× 127 0.7× 84 0.5× 145 0.8× 42 1.4k
Yiwei Li China 17 457 1.3× 80 0.3× 114 0.6× 105 0.6× 77 0.4× 35 1.1k
Zhangyin Ming China 19 556 1.5× 71 0.3× 146 0.8× 71 0.4× 236 1.4× 39 1.3k

Countries citing papers authored by Jie-Jen Lee

Since Specialization
Citations

This map shows the geographic impact of Jie-Jen Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie-Jen Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie-Jen Lee more than expected).

Fields of papers citing papers by Jie-Jen Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie-Jen Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie-Jen Lee. The network helps show where Jie-Jen Lee may publish in the future.

Co-authorship network of co-authors of Jie-Jen Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jie-Jen Lee. A scholar is included among the top collaborators of Jie-Jen Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie-Jen Lee. Jie-Jen Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chien‐Liang, Yi‐Chiung Hsu, Jie-Jen Lee, et al.. (2019). Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells. Molecular and Cellular Endocrinology. 499. 110595–110595. 49 indexed citations
2.
Lee, Jie-Jen, et al.. (2017). Recurrence-associated genes in papillary thyroid cancer: An analysis of data from The Cancer Genome Atlas. Surgery. 161(6). 1642–1650. 25 indexed citations
3.
Lee, Jie-Jen, Tao-Yeuan Wang, Chien‐Liang Liu, et al.. (2017). Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 102(8). 2930–2940. 66 indexed citations
4.
Cheng, Shih‐Ping, Yi‐Chiung Hsu, Chien‐Liang Liu, et al.. (2014). Significance of Allelic Percentage of BRAF c.1799T > A (V600E) Mutation in Papillary Thyroid Carcinoma. Annals of Surgical Oncology. 21(S4). 619–626. 32 indexed citations
6.
Lee, Jie-Jen, et al.. (2014). Pharmacology and Clinical Effect of Platonin, a Cyanine Photosensitizing Dye: Potential Molecular Targets. Current Pharmaceutical Biotechnology. 15(8). 700–711. 2 indexed citations
7.
Lin, Jiunn-Chang, Wei‐Pang Huang, Chien‐Liang Liu, et al.. (2013). Sorafenib Induces Autophagy in Human Myeloid Dendritic Cells and Prolongs Survival of Skin Allografts. Transplantation. 95(6). 791–800. 17 indexed citations
8.
Cheng, Shih‐Ping, Chien‐Liang Liu, Yi‐Chiung Hsu, et al.. (2012). Regulation of leptin receptor expression in human papillary thyroid cancer cells. Biomedicine & Pharmacotherapy. 66(6). 469–473. 18 indexed citations
9.
Cheng, Shih‐Ping, Chien‐Liang Liu, Yi‐Chiung Hsu, et al.. (2012). Expression and Biologic Significance of Adiponectin Receptors in Papillary Thyroid Carcinoma. Cell Biochemistry and Biophysics. 65(2). 203–210. 48 indexed citations
10.
Lu, Wan‐Jung, Jie-Jen Lee, Duen‐Suey Chou, et al.. (2011). A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP. Journal of Molecular Medicine. 89(12). 1261–1273. 73 indexed citations
11.
Lee, Jie-Jen, Wen-Hsien Hsu, Ting‐Lin Yen, et al.. (2011). Traditional Chinese medicine, Xue-Fu-Zhu-Yu decoction, potentiates tissue plasminogen activator against thromboembolic stroke in rats. Journal of Ethnopharmacology. 134(3). 824–830. 54 indexed citations
12.
Chang, Chao-Chien, Jie-Jen Lee, Michael F. Chiang, et al.. (2010). Inhibitory effect of PMC, a potent hydrophilic α-tocopherol derivative, on vascular smooth muscle cell proliferation: The pivotal role of PKC-α translocation. Pharmaceutical Biology. 48(8). 938–946. 5 indexed citations
13.
Wu, Gong‐Jhe, Jie-Jen Lee, Duen‐Suey Chou, et al.. (2010). Inhibitory signaling of 17β-estradiol in platelet activation: The pivotal role of cyclic AMP-mediated nitric oxide synthase activation. European Journal of Pharmacology. 649(1-3). 140–149. 15 indexed citations
14.
Lee, Jie-Jen, et al.. (2009). Stimulatory effect of stevioside on peripheral mu opioid receptors in animals. Neuroscience Letters. 454(1). 72–75. 20 indexed citations
15.
Lin, Jiunn-Chang, et al.. (2009). Increased percentage of B cells in patients with more advanced hepatocellular carcinoma. Human Immunology. 71(1). 58–62. 10 indexed citations
16.
Chen, Tyng‐Guey, et al.. (2007). Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.. PubMed. 50(3). 121–6. 17 indexed citations
17.
Hsiao, George, Jie-Jen Lee, Yi-Cheng Chen, et al.. (2006). Neuroprotective effects of PMC, a potent α-tocopherol derivative, in brain ischemia-reperfusion: Reduced neutrophil activation and anti-oxidant actions. Biochemical Pharmacology. 73(5). 682–693. 30 indexed citations
18.
Lin, Jiunn-Chang, et al.. (2006). Induction of apoptosis and cell-cycle arrest in human colon cancer cells by meclizine. Food and Chemical Toxicology. 45(6). 935–944. 27 indexed citations
19.
Lee, Jie-Jen, et al.. (2006). Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation. European Journal of Pharmacology. 537(1-3). 52–58. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026